Skip to content
Search

Latest Stories

WHO rejects tobacco companies' harm reduction claims in a new report

WHO rejects tobacco companies' harm reduction claims in a new report
The WHO condemns tobacco companies' targeting of children through social media and flavored products

The World Health Organization (WHO) reiterated its concerns about tobacco companies' continued targeting of young people through various channels such as social media, sports, and music festivals, as well as the introduction of flavored products.

In a joint report with industry watchdog STOP released on Thursday, the WHO accused these companies of attempting to ensnare a new generation in nicotine addiction.


While facing stricter regulations on traditional cigarettes, major tobacco firms and newcomers have turned to alternatives like vapes, arguing they are intended for adult smokers.

However, the WHO and STOP highlighted in their report that these products often appeal to youth, with their attractive designs and fruity flavors making them more appealing to children than to adults in many countries.

WHO Director-General Tedros Adhanom Ghebreyesus dismissed the industry's claims of harm reduction, asserting that it's misleading to discuss harm reduction while marketing to children.

He stated in the report, "It's dishonest to talk about harm reduction when they are marketing to children."

This stern stance from the WHO comes as youth vaping rates soar globally.

Flavors like bubblegum have been identified as drivers of this trend, although the industry maintains that flavors play a crucial role in persuading adults to transition from smoking.

While large tobacco companies have largely refrained from offering such flavors, the WHO pointed out that firms like Philip Morris International (PMI) and British American Tobacco (BAT) engage in youth-oriented marketing tactics, including sponsoring music and sports events and leveraging social media.

Both PMI and BAT stated their intentions to shift smokers away from cigarettes, with BAT emphasising responsible marketing principles and ensuring products are for adults only.

PMI stressed the importance of scientifically substantiated smoking alternatives and expressed willingness to engage with governments and the WHO on the matter.

Despite these assertions, the WHO highlighted insufficient evidence supporting vapes as smoking cessation aids and pointed out evidence suggesting an increase in traditional cigarette use, particularly among youth, due to vaping.

However, Sarah Jackson from University College London's Tobacco and Alcohol Research Group disputed these claims, stating to Reuters that they do not accurately represent current evidence on e-cigarettes.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less